Non-Current Assets
Accumulated Depreciation
Gilead Sciences Accumulated Depreciation increased by 3.3% to $2.78B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.5%, from $2.54B to $2.78B. Over 5 years (FY 2020 to FY 2025), Accumulated Depreciation shows a downward trend with a -16.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2015
Last reportedQ1 2026May 7, 2026
Parent metricPP&E (Net)
Metric ID:
ppe_accumulated_depreciationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.5B | $7.94B | $8.38B | $8.83B | $9.25B | $9.7B | $10.12B | $10.67B | $11.27B | $11.86B | $12.44B | $13.03B | $13.63B | $14.22B | $2.47B | $2.54B | $2.62B | $2.69B | $2.7B | $2.78B |
| QoQ Change | — | +5.9% | +5.6% | +5.3% | +4.8% | +4.8% | +4.3% | +5.4% | +5.6% | +5.3% | +4.8% | +4.8% | +4.6% | +4.4% | -82.6% | +2.9% | +3.1% | +2.7% | +0.1% | +3.3% |
| YoY Change | — | — | — | — | +23.5% | +22.2% | +20.8% | +20.8% | +21.7% | +22.3% | +22.9% | +22.2% | +21.0% | +19.9% | -80.1% | -80.5% | -80.8% | -81.1% | +9.1% | +9.5% |
| % of PP&E (Net) | 150.0% | 157.6% | 163.7% | 168.0% | 174.6% | 181.3% | 184.9% | 194.7% | 203.3% | 212.9% | 233.9% | 244.9% | 254.9% | 263.8% | 45.6% | 46.9% | 48.0% | 49.0% | 48.1% | 49.4% |
| Share Change | — | +7.5pp | +6.1pp | +4.4pp | +6.6pp | +6.7pp | +3.5pp | +9.8pp | +8.7pp | +9.6pp | +21.0pp | +11.0pp | +10.0pp | +8.9pp | -218.2pp | +1.3pp | +1.1pp | +1.0pp | -0.9pp | +1.3pp |
Range$2.47B – $14.22B
CAGR-18.8%
Avg YoY Growth-5.4%
Median YoY Growth+20.8%
Current Streak5 quarters growth
Accumulated Depreciation at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's accumulated depreciation?
- Gilead Sciences (GILD) reported accumulated depreciation of $2.78B in Q1 2026.
- How has Gilead Sciences's accumulated depreciation changed year-over-year?
- Gilead Sciences's accumulated depreciation increased by 9.5% year-over-year, from $2.54B to $2.78B.
- What is the long-term trend for Gilead Sciences's accumulated depreciation?
- Over 5 years (2020 to 2025), Gilead Sciences's accumulated depreciation has grown at a -16.5% compound annual growth rate (CAGR), from $6.66B to $2.7B.